Based on the Terumo Corporation stock forecast from 0 analysts, the average analyst target price for Terumo Corporation is not available over the next 12 months. Terumo Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Terumo Corporation is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, Terumo Corporation’s stock price was USD 19.22. Terumo Corporation’s stock price has changed by -7.42% over the past week, +4.00% over the past month and -29.97% over the last year.
No recent analyst target price found for Terumo Corporation
No recent average analyst rating found for Terumo Corporation
Company Overview Terumo Corporation
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan. Read Less
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and...Read More
Frequently Asked Questions About Terumo Corporation (TRUMF) Stock
Stock Target Advisor's fundamental analysis for Terumo Corporation's stock is Bullish .
TRUMF stock's dividend yield is 0.95%.
Our analysis grades TRUMF stock's dividend yield at F. This means that TRUMF stock's dividend yield is above 36% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this TRUMF may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on TRUMF's stock to indicate what its average analyst target is.
TRUMF stock's Price/Earning ratio is 35.27.
Our analysis grades TRUMF stock's Price / Earning ratio at C+. This means that TRUMF stock's Price/Earning ratio is above 21% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this TRUMF may be undervalued for its sector.
The last closing price of TRUMF's stock was USD 19.22.
The most recent market capitalization for TRUMF is USD 28.18B.
Unfortunately we do not have enough analyst data on TRUMF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Terumo Corporation's stock.
As per our most recent records Terumo Corporation has 0 Employees.
Terumo Corporation's registered address is 2-44-1, Hatagaya, Tokyo, Japan, 151-0072.
You can get more information about it from Terumo Corporation's website at https://www.terumo.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Terumo Corporation (TRUMF) Stock
Stock Target Advisor's fundamental analysis for Terumo Corporation's stock is Bullish .
TRUMF stock's dividend yield is 0.95%.
Our analysis grades TRUMF stock's dividend yield at F. This means that TRUMF stock's dividend yield is above 36% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this TRUMF may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on TRUMF's stock to indicate what its average analyst target is.
TRUMF stock's Price/Earning ratio is 35.27.
Our analysis grades TRUMF stock's Price / Earning ratio at C+. This means that TRUMF stock's Price/Earning ratio is above 21% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this TRUMF may be undervalued for its sector.
The last closing price of TRUMF's stock was USD 19.22.
The most recent market capitalization for TRUMF is USD 28.18B.
Unfortunately we do not have enough analyst data on TRUMF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Terumo Corporation's stock.
As per our most recent records Terumo Corporation has 0 Employees.
Terumo Corporation's registered address is 2-44-1, Hatagaya, Tokyo, Japan, 151-0072.
You can get more information about it from Terumo Corporation's website at https://www.terumo.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TRUMF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
